Time-Action Profile of the Long-Acting Insulin Analog Insulin Glargine (HOE901) in Comparison With Those of NPH Insulin and Placebo

Heinemann, Lutz; Linkeschova, Renata; Rave, Klaus; Hompesch, Beate; Sedlak, Martin; Heise, Tim
May 2000
Diabetes Care;May2000, Vol. 23 Issue 5, p644
Academic Journal
Presents information on a study which investigated the pharmacodynamic properties of the subcutaneously injected long-acting insulin analog HOE901 in comparison with those of NPH insulin and placebo. Research design and methods; Results; Conclusions.


Related Articles

  • Administration of Insulin to Type 1 Diabetes-Current Nursing Practice. Kamaraj, Anjuladevi; Gandhimathi, M.; Ramesh, C. // International Journal of Nursing Education;Jan-Jun2014, Vol. 6 Issue 1, p6 

    No abstract available.

  • What makes insulin injections painful? Chantelau, E.; Lee, D.M.; Hemmann, D.M.; Zipfel, U.; Echterhoff, S. // BMJ: British Medical Journal (International Edition);7/6/91, Vol. 303 Issue 6793, p26 

    Evaluates the pain of subcutaneous injection in diabetic patients being treated with insulin. Information of the subjects involved in the study; Discussion on the pain perception among five different volumes; Factors associated with the pain of subcutaneous injection.

  • What is the best way to deliver subcutaneous insulin to infants, children, and young people with type 1 diabetes mellitus? Blair, J. C.; Peak, M.; Gregory, J. W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/10/2011, Vol. 343 Issue 7822, p532 

    The article presents questions and answers concerning the proper method of administering insulin to infants, children and young people with type 1 diabetes mellitus.

  • Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. DE LA PE√ĎA, AMPARO; RIDDLE, MATTHEW; MORROW, LINDA A.; JIANG, HONGHUA H.; LINNEBJERG, HELLE; SCOTT, ADAM; WIN, KHIN M.; HOMPESCH, MARCUS; MACE, KENNETH F.; JACOBSON, JENNIE G.; JACKSON, JEFFREY A. // Diabetes Care;Dec2011, Vol. 34 Issue 12, p2496 

    OBJECTIVE--Human regular U-500 (U-500R) insulin (500 units/mL) is increasingly being used clinically, yet its pharmacokinetics (PK) and pharmacodynamics (PD) have not been well studied. Therefore, we compared PK and PD of clinically relevant doses of U-500R with the same doses of human regular...

  • Subcutaneous injection technique: an evidence-based approach. Ogston-Tuck, Sherri // Nursing Standard;9/17/2014, Vol. 29 Issue 3, p53 

    Injections are routinely administered by nurses in acute care settings and in the community. Nurses require a thorough understanding of anatomy and physiology, pharmacological principles and equipment, and potential risks to the patient of injections. Nurses should also take an active approach...

  • In pursuit of excellence in diabetes care: trends in insulin delivery. Meetoo, Danny; McAllister, Gillian; West, Adele; Turnbull, Mandy // British Journal of Nursing;5/24/2012, Vol. 21 Issue 10, p588 

    Diabetes mellitus has been estimated to affect 2.9 million people in the UK. Large-scale clinical trials conclusively demonstrate that elevated blood glucose levels are associated with an increased risk of micro- and macrovascular complications. The high rates of morbidity and mortality...

  • 'Ultra long-acting' insulins to end daily jabs. Moberly, Tom // Independent Nurse;4/16/2010, p1 

    The article discusses the 'ultra long-acting new generation insulins' which need to be injected twice a week instead of conventional daily jabs. The products developed by Novo Nordisk, are of 2 types where one is tested to use three times a week and the other at meal times. The injections are...

  • Glatiramer acetate.  // Reactions Weekly;3/17/2012, Issue 1393, p22 

    The article describes the case of a woman who experienced injection site reactions after receiving subcutaneous self-injections of glatiramer acetate for multiple sclerosis.

  • Importance of injection technique in diabetes. Pledger, Julia; Hicks, Debbie; Kirkland, Fiona; Down, Su // Journal of Diabetes Nursing;2012, Vol. 16 Issue 4, p160 

    It is estimated that approximately 800 000 people in the UK use injectable therapies to treat their diabetes (Forum for Injection Technique, 2010). Injectable agents, both old and new, rely for optimal effect on the correct dose being injected at the right site, using the right technique every...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics